Clinical data company TARGET PharmaSolutions of Chapel Hill will collaborate with Dublin-based Allergan, a global pharmaceutical company, to study a major liver disease and future treatment options for it.
A genetic test developed by MultiGEN Diagnostics of Greensboro is 1,000 times more sensitive than current methods in detecting a key mutation in cancer, according to a newly published scientific paper.
Clinical Sensors Inc., a small diagnostic device company in Research Triangle Park, has won two grants totaling more than $1.5 million from the National Institutes of Health (NIH) to support the development of its point-of-care device that measures a patient's blood nitric oxide level within a few seconds.
NeuroTronik Inc. of Durham has closed on $23.1 million in Series B preferred stock financing to advance its therapy for treating acute heart failure in hospitals.
The Durham-based venture capital firm Hatteras Venture Partners was a major investor, along with lead investor Boston Scientific Group and others including Synergy Life Science Partners, Lord Baltimore Investment Partners, Mountain Group Capital and Sovereign’s Capital.
Craft Technologies, a small contract laboratory in Wilson, has received federal certification in the measurement of estradiol, a metabolite of the sex hormone estrogen that is useful in assessing many diseases and disorders.
RTP's AgTech Accelerator has made a $5 million investment to establish a new animal health company, Skyline Vet Pharma, to in-license and develop drug delivery technologies aimed at improving veterinary treatment of companion animals – primarily dogs and cats.
Middle and high school teachers have an opportunity to expand their knowledge of agricultural biotechnology in a pair of Industry in the Classroom workshops beginning in July, organized by the North Carolina Biotechnology Center.